CA1038762A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
CA1038762A
CA1038762A CA229,564A CA229564A CA1038762A CA 1038762 A CA1038762 A CA 1038762A CA 229564 A CA229564 A CA 229564A CA 1038762 A CA1038762 A CA 1038762A
Authority
CA
Canada
Prior art keywords
les
par
principe actif
excipient
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA229,564A
Other languages
English (en)
French (fr)
Inventor
Claude Bonne
Jacques Perronnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of CA1038762A publication Critical patent/CA1038762A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA229,564A 1974-06-21 1975-06-17 Pharmaceutical compositions Expired CA1038762A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7421603A FR2275206A1 (fr) 1974-06-21 1974-06-21 Application d'une oxazolidinedione a titre de medicament

Publications (1)

Publication Number Publication Date
CA1038762A true CA1038762A (en) 1978-09-19

Family

ID=9140360

Family Applications (1)

Application Number Title Priority Date Filing Date
CA229,564A Expired CA1038762A (en) 1974-06-21 1975-06-17 Pharmaceutical compositions

Country Status (7)

Country Link
US (1) US4000291A (US20070167544A1-20070719-C00007.png)
BE (1) BE830474A (US20070167544A1-20070719-C00007.png)
CA (1) CA1038762A (US20070167544A1-20070719-C00007.png)
DE (1) DE2527579A1 (US20070167544A1-20070719-C00007.png)
FR (1) FR2275206A1 (US20070167544A1-20070719-C00007.png)
GB (1) GB1461897A (US20070167544A1-20070719-C00007.png)
NL (1) NL7507370A (US20070167544A1-20070719-C00007.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE69051T1 (de) * 1985-10-11 1991-11-15 Sagami Chem Res Oxazolidindionabkoemmlinge, deren herstellungsverfahren und unkrautvertilgungsmittel, die diese enthalten.
FR2751965B1 (fr) * 1996-08-01 1998-11-27 Oreal Nouveaux composes de la famille des aryl-2,4-dioxo-oxazolidines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909467A (en) * 1958-07-09 1959-10-20 Us Vitamin Pharm Corp 3-(d-alpha-methylphenethyl)-5-methyl-1, 3-oxazolidine-2, 4-dione
CA926407A (en) * 1967-12-01 1973-05-15 Horiuchi Fukashi 3-(3,4-dichlorophenyl) oxazolidine-2,4-dione derivatives
GB1252101A (US20070167544A1-20070719-C00007.png) * 1969-03-18 1971-11-03

Also Published As

Publication number Publication date
NL7507370A (nl) 1975-12-23
BE830474A (fr) 1975-12-22
FR2275206A1 (fr) 1976-01-16
FR2275206B1 (US20070167544A1-20070719-C00007.png) 1978-07-21
DE2527579A1 (de) 1976-01-08
GB1461897A (en) 1977-01-19
US4000291A (en) 1976-12-28

Similar Documents

Publication Publication Date Title
KR20080016948A (ko) 신규 트리테르펜산 유도체 및 이를 포함하는 피부 외용제
FR2734158A1 (fr) Association d'un compose a activite anti-microbienne et d'un monoalkylether de glycerol
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
CA1242458A (fr) Ethers-oxydes et ethers-oximes d'alcoylaminoalcools comme medicaments, produits nouveaux et procedes pour leur preparation
EP0308564B1 (fr) Composition inhibitrice ou destructrice d'au moins un être vivant unicellulaire renfermant un fluorure d'ammononium quaternaire et procédé de préparation de ce sel
CA1038762A (en) Pharmaceutical compositions
CA2269895A1 (fr) Utilisation d'un extrait flavonoidique de ginkgo biloba substantiellement depourvu de terpenes, dans le domaine bucco-dentaire, et composition contenant un tel extrait
EP0829256A1 (fr) Utilisation d'un agoniste des récepteurs des rétinoides de type RXR pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2542614A1 (fr) Compositions pharmaceutiques a activite anti-neoplastique, comprenant un compose de selenium et un acide carboxylique, un aldehyde ou une cetone
EP3268008B1 (fr) Composés analogues de la squalamine utiles comme agents antibactériens
WO1996014840A1 (en) Use of menthyl lactate as a pain reliever
EP0387314B1 (fr) Utilisation d'agent actif contre les retrovirus et produits ainsi mis en uvre
CA1039301A (en) Process for preparing novel monohydroxyphenethylamines and their salts
EP1998779A2 (fr) Utilisation du (3s)-n-hydroxy-4-({4-ý(4-hydroxy-2-butynyl)oxy]phényl}sulfonyl)-2,2-diméthyl-3-thiomorpholine carboxamide ou du (s)-n-hydroxy-4-(4-but-2-ynyloxy-benzenesulfonyl) -2,2-dimethyl-thiomorpholine -3-carboxamide dans le traitement de pathologies inflammatoires cutanées
JP3200723B2 (ja) 育毛剤
EP0520865A1 (fr) Utilisation de dérivés d'acide pour la fabrication d'un médicament pédiculicide
WO2008068427A2 (fr) Composition terpénique anti-microorganisme
WO2003000208A1 (fr) Composition a usage topique comprenant un produit cytotoxique
CN1243749A (zh) 环加氧酶抑制剂
FR2520230A1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
CA1140111A (fr) PROCEDE DE PREPARATION D'UN NOUVEAU DERIVE DU (20S) 3.alpha.- /(AMINO-ACETYL)AMINO/ 5.alpha.-PREGNAN-20-OL ET DE SES SELS
JP2516477B2 (ja) 皮膚の血行不良に起因する疾患の治療剤
CA1144072A (fr) Compositions pharmaceutiques et cosmetiques
FR2566665A1 (fr) Composition pour inhiber le developpement des tumeurs, a base d'un derive d'acide peroxydiphosphorique
JP2007246459A5 (US20070167544A1-20070719-C00007.png)